FDA panel members may have felt like they'd been backed into a wall with the Moderna booster EUA recommendation so closely following the Pfizer/BioNTech authorization. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
